1887

Abstract

The reactivity of D antigen-specific monoclonal antibodies with infectious virus and inactivated virus in commercial poliovaccines from two manufacturers was examined in capture enzyme immunoassays. Epitopes on inactivated poliovirus types 2 and 3 in vaccines were modified by the inactivation process to such an extent that some monoclonal antibodies which bound to the homologous infectious virus strain failed to bind to the inactivated virus in the vaccine. This was especially the case for antibodies specific for site 1, which elicits the major immune response to these serotypes in mice. Other epitopes were partially destroyed resulting in a reduction in reactivity of monoclonal antibodies with inactivated virus in vaccines compared to infectious virus. These studies indicate that inactivated virus in vaccine differs antigenically from native virus so that measuring the potency of vaccine in assays may require careful selection of an appropriate antibody. In addition it is possible that some of the antibodies produced by recipients of formalin-inactivated polioviruses may not contribute to the protective immune response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-4-685
1993-04-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/4/JV0740040685.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-4-685&mimeType=html&fmt=ahah

References

  1. Beale A. J., Ungar J. 1962; Potency and stability of combined pertussis, diphtheria, tetanus and poliomyelitis (quadruple) vaccine. Lancet ii:805–808
    [Google Scholar]
  2. Brioen P., Sijens R. J., Vrijsen R., Rombaut B., Thomas A. AM., Jackers A., Boeye A. 1982; Hybridoma antibodies to poliovirus N and H antigen. Archives of Virology 74:325–330
    [Google Scholar]
  3. Ferguson M., Minor P. D. 1990; Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus. Journal of General Virology 71:1271–1274
    [Google Scholar]
  4. Ferguson M., Minor P. D., Magrath D. I., Qui Y. FL., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
    [Google Scholar]
  5. Finney D. J. 1978 Statistical Methods in Biological Assay, 3rd edn. London: Griffin;
    [Google Scholar]
  6. Kinnunen L., Hovi T. 1989; Partial RNA sequencing of eight supposed derivatives of type 3 poliovirus/USA/Saukett/50 reveals remarkable differences between three apparent substrains. Virology 170:316–320
    [Google Scholar]
  7. Le Bouvier G. L. 1955; The modification of poliovirus antigens by heat and ultraviolet light. Lancet ii:1013–1016
    [Google Scholar]
  8. Mayer M. M., Rapp FI. J, Roizman B., Klein S. W., Cowan K. M., Lukens D., Schwerdt C. E., Schaffer F. L., Charney J. 1957; The purification of poliomyelitis virus as studied by complement fixation. Journal of Immunology 78:435–155
    [Google Scholar]
  9. Minor P. D. 1990; Antigenic structure of picornaviruses. Current Topics in Microbiology and Immunology 161:121–154
    [Google Scholar]
  10. Minor P. D., Schild G. C., Wood J. M., Dandawate C. N. 1980; The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations. Journal of General Virology 51:147–156
    [Google Scholar]
  11. Minor P. D., Schild G. C., Ferguson M., Mackay A., Magrath D. I., John A., Yates P. J., Spitz M. 1982; Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. Journal of General Virology 61:167–176
    [Google Scholar]
  12. Minor P. D., Ferguson M., Phillips A., Magrath D. I., Huovilainen A., Flovi T. 1987; Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. Journal of General Virology 68:1857–1865
    [Google Scholar]
  13. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1991; Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1. Journal of General Virology 71:2543–2551
    [Google Scholar]
  14. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1991; Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4. Journal of General Virology 72:2475–2481
    [Google Scholar]
  15. Murdin A. D., Wimmer E. 1989; Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. Journal of Virology 63:5251–5257
    [Google Scholar]
  16. Patel V., Ferguson M., Minor P. D. 1993; Antigenic sites in type 2 poliovirus. Virology 192:361–364
    [Google Scholar]
  17. Singer C., Knauert F., Bushar G., Klutch M., Lundquist R., Quinnan G. V. Jr 1989; Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies. Journal of Biological Standardization 17:137–150
    [Google Scholar]
  18. Souvras M., Montagnon B., Fanget B., van Wezel A. L., Hazendonk A. G. 1980; Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis D-antigen. Developments in Biological Standardization 46:197–202
    [Google Scholar]
  19. Uhlig H., Rutter G., Dernick R. 1983; Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA). Journal of General Virology 64:2809–2812
    [Google Scholar]
  20. van der Marel P., Hazendonk A. G., van Wezel A. L. 1980; D antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods. Developments in Biological Standardization 47:101–108
    [Google Scholar]
  21. van Ramshorst J. D., Polar M. F. 1966; The in vitro determination of the D antigens of poliomyelitis viruses. 1. The gel diffusion test. Immunology 11:297–311
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-4-685
Loading
/content/journal/jgv/10.1099/0022-1317-74-4-685
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error